Tyler, V. Herbs of Choice, Pharmaceutical Products Press, pp. 81-86, 1994.* |
Blumenthal et al. The Complete German Commission E Monographs, pp. 193, 201, and 217, 1998.* |
Product Alert Bulletin—Oct. 5, 1992, see abstract.* |
E. Koch and A. Biber, “Pharmacological Effects of Saw Palmetto and Urtica Extracts for Benign Prostatic Hyperplasia”. Urologe (1994), 34(2): 90-95. |
W. Vahlensieck, et al. “Benign Prostatic Hyperplasia: Treatment with Sabal Fruit Extract. Observational study on 1334 patients”. Fortschritte der Therapy (1993), 111:323-326, English summary on p. 326. |
J. Braeckman, “The extract of Serenoa Repens in the Treatment of Benign Prostatic Hyperplasia; a multicenter open study”. Current Therapeutic Research (1994), 55(7); 776-785. |
B.E. Carbin et al. “Treatment of Benign Prostatic Hyperplasia with Phytosterols”. British Journal of Urology (1990), 66:639-641. |
M. Krieg, et al.. “Effect of Aging on Endogenous Level of 5a-Dihydrotestosterone, Testosterone, Estradiol, and Estrone in Epithelium and Stroma of Normal and Hyperplastic Human Prostate”. Journal of Clinical Endocrinology (1993), 77(2):375-381. |
N.G. Bisset,“Herbal Drugs and Phytopharmace Uticals” Medpharm GmbH Scientific Publishers (1994), pp. 508-509. (nettle root); pp. 170-172 (pumpkin seed). |
H.J. Schneider, et al. “Treatment of Benign Prostatic Hyperplasia: Results of a surveilance study in practices of urological specialists using a combined plant-based preparation (Sabal extract WS 1473 and Urtica extract WS 1031)”. (1995) Fortschr Med., 11(3): 37-40. (abstract only). |
D. Brown, “Efficacy of Saw Palmetto/Urtica Root in the Treatment of BPH”, Quarterly Review of Natural Medicine (Winter 1995), pp. 279-280. |
W. Breu, et al. “Der Sabalfrucht-Extrakt SG 291”., Zeitschrift fur Phytotherapie 13 (1992), pp. 107-115 (English abstract p. 115). |
T.J. Wilt, et al. “Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia”, Quarterly Review of Natural Medicine (Winter 1995), pp. 279-280. |
L. Rhodes,et al. “Comparison of Finasteride (Proscar®), a 5a Reductase Inhibitor, and Various Commercial Plant Extracts in In Vitro and In Vivo 5a Reductase Inhibition”. The Prostate (1993), 22:43-51. |